FDA Updates Hormone Therapy Warnings

U.S. health officials remove serious warning label from hormone-based medications, citing new evidence suggesting fewer risks when started before age sixty or within ten years of menopause symptoms. The updated label aims for a more balanced approach, with benefits potentially extending beyond symptom management to include heart disease, bone fractures, and Alzheimers prevention. The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.